RLRanny Beatriz de Carvalho Holanda Leite

Ranny Beatriz de Carvalho Holanda Leite

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ranny Beatriz de Carvalho Holanda Leite has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Cecília Maria de Carvalho Xavier Holanda

    Laboratory of Experimental Bioavailability and Antiparasitic Tests, Department of Microbiology and Parasitology, UFRN, Natal, Brazil

    1 shared publication
  • Clarice Maux Vianna da Silva

    School of Medicine, Federal University of Rio Grande do Norte (UFRN), Natal, Brazil

    1 shared publication
  • Cláudio Bruno Silva de Oliveira

    Uninassau College, Natal, Brazil

    1 shared publication
  • Joelma Maria de Araújo Andrade

    Hemocentro Dalton Cunha, Brasil

    1 shared publication
  • João Cláudio da Costa Urbano

    School of Medicine, Federal University of Rio Grande do Norte (UFRN), Natal, Brazil

    1 shared publication
  • Renan Leopoldo Pereira Castro

    School of Medicine, Federal University of Rio Grande do Norte (UFRN), Natal, Brazil

    1 shared publication

Latest Publications

  • Effect of toxoplasmic infection on the biodistribution of a brain radiopharmaceutical

    by João Cláudio da Costa Urbano, Ranny Beatriz de Carvalho Holanda Leite, Renan Leopoldo Pereira Castro, Clarice Maux Vianna da Silva, Joelma Maria de Araújo Andrade, Cláudio Bruno Silva de Oliveira, Vanessa Santos de Arruda Barbosa, Valter Ferreira de Andrade-Neto, Cecília Maria de Carvalho Xavier Holanda

    Purpose: This study evaluated if Toxoplasma gondii infection and the drug-associated infection modifies the brain radiopharmaceutical Ethylene Cystine Diethylester Dihydrochloride (99mTc-ECD) biodistribution in mice. Materials and methods: A total of 18 mice were divided into 3 groups. Control group (C) received distilled water and 99mTc-ECD; Infected group (I) received T. gondii strain and 99mTc-ECD; Infected and Treated group (IT), in addition to infection, received association of Pyrimethamine and Sulfadiazine and 99mTc-ECD. The T. gondii strain used in this study was TgCkRrRN3. Forty minutes after administration of the 99mTc-ECD, all animals were euthanized, and blood and brain samples were isolated. The counting of the radioactivity percentage per gram of tissue (%ATI/g) was calculated, and statistical analysis was performed by t-test, with a level of significance of p < .05. Results: There was a significant increase in %ATI/g between groups C and I on brain (0.35 ± 0.02 and 0.45 ± 0.04; p = .041) and on blood (0.80 ± 0.09 and 1.14 ± 0.31; p = .049). A significant decrease in %ATI/g occurred between groups C and IT on blood (0.80 ± 0.09 and 0.54 ± 0.08; p = .001) and on brain (0.35 ± 0.02 and 0.22 ± 0.04; p = .049). Conclusions: Combined therapy of anti-Toxoplasma drugs in infected mice reduced the uptake of 99mTc-ECD, probably due to its binding to plasma proteins.